Back to search
Recurrent Severe Aplastic Anemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Severe Aplastic Anemia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Severe Aplastic Anemia trials you may qualify forThis phase I trial evaluates the safety and feasibility of using a reduced-intensity regimen of cyclophosphamide, pentostatin, and anti-thymocyte globulin prior…
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in…
This trial is exploratory research aimed at evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD13-02, a universal CD7 CA…
RATIONALE: Infection prophylaxis and management may help prevent cytomegalovirus (CMV) infection caused by a stem cell transplant. PURPOSE:This clinical trial…
This was a non-randomized, open-label, phase II study to assess the efficacy and safety of eltrombopag in Chinese subjects with refractory or relapsed severe ap…